Valuation: Genpharmasec Limited

Market Cap 592M 6.16M 5.48M 5.11M 4.66M 8.79M 8.87M 61.85M 23.97M 303M 23.14M 22.64M 972M P/E 2025
94.5x
P/E 2026 26.9x
Enterprise Value 841M 8.75M 7.77M 7.26M 6.61M 12.47M 12.59M 87.82M 34.03M 430M 32.85M 32.14M 1.38B EV / Sales 2025
2.96x
EV / Sales 2026 0.49x
Free-Float
54.91%
Yield 2025 *
-
Yield 2026 -
1 day-4.46%
1 week-6.96%
Current month-4.46%
1 month-13.71%
3 months-6.14%
Current year-18.32%
1 week 1.05
Extreme 1.05
1.17
1 month 1.05
Extreme 1.05
1.33
Current year 0.75
Extreme 0.75
1.45
1 year 0.75
Extreme 0.75
1.91
3 years 0.75
Extreme 0.75
8.71
5 years 0.75
Extreme 0.75
11.08
10 years 0.75
Extreme 0.75
18
Manager TitleAgeSince
Director of Finance/CFO 39 2022-10-31
Compliance Officer - 2024-03-26
Director TitleAgeSince
Director/Board Member 57 2019-01-01
Director/Board Member 58 2019-01-01
Director/Board Member - 2022-10-31
Change 5-day change 1-year change 3-year change Capi.($)
-4.46%-6.96%-43.39%-73.05% 6.16M
+0.84%-3.74%-26.69%+1.85% 169B
-0.07%-2.55%-9.53%+11.07% 110B
+0.90%+1.13%-24.83%+0.58% 106B
-1.24%-0.76%-49.04%-12.75% 73.87B
-0.24%+0.69%+0.16%+72.58% 58.98B
-0.86%+2.96%+13.57%+59.50% 51.28B
-0.71%-3.82%-7.72%-31.41% 48.16B
+0.12%-0.17%-18.21%+20.29% 40.84B
-1.01%-1.45%+28.48%-9.72% 32.21B
Average -0.67%-1.22%-13.72%+3.89% 69.02B
Weighted average by Cap. +0.03%-1.30%-16.36%+10.13%

Financials

2025 2026
Net sales 337M 3.51M 3.12M 2.91M 2.65M 5M 5.05M 35.2M 13.64M 172M 13.17M 12.88M 553M 1.4B 14.56M 12.93M 12.07M 11M 20.75M 20.94M 146M 56.61M 715M 54.65M 53.47M 2.3B
Net income 12.31M 128K 114K 106K 96.8K 183K 184K 1.29M 498K 6.29M 481K 470K 20.2M 16.04M 167K 148K 138K 126K 238K 240K 1.67M 649K 8.2M 626K 613K 26.31M
Net Debt -9.4M -97.81K -86.91K -81.11K -73.93K -139K -141K -982K -380K -4.81M -367K -359K -15.43M 249M 2.59M 2.3M 2.15M 1.96M 3.69M 3.72M 25.97M 10.06M 127M 9.71M 9.5M 408M
Logo Genpharmasec Limited
Genpharmasec Limited is an India-based company, which is engaged in the distribution of diagnostic pharma equipment and trading of securities. The Company’s segments include Pharmaceuticals, Trading in Securities, and Laboratory Testing. The Trading in Securities segment invests in the secondary securities market. The Company holds rights to the distribution of equipment, such as i-STAT Analyzers and its Cartridges, manufactured by Abbott Point of Care, USA, all over India. The i-STAT Analyzer is a blood analyzer used in Intensive Care Units (ICUs) of hospitals and provides test results in approximately 10 minutes. The Company’s wholly owned subsidiary includes M/s. Clinigenome India Private Limited.
Employees
13
Date Price Change Volume
26-10-01 ₹1.070 -4.46% 299,160
26-09-30 ₹1.120 0.00% 158,401
26-09-29 ₹1.120 -0.88% 221,930
26-09-28 ₹1.130 -1.74% 133,896
26-09-25 ₹1.150 +2.68% 326,801
  1. Stock Market
  2. Stocks
  3. ADIRASA Stock